MedCity News

JUNE 25, 2023

Apogee Therapeutics is planning an IPO to fund clinical development of biologic drugs that could offer dosing advantages over currently available immunology and inflammation drugs. Its lead program is being prepared for Phase 1 testing in atopic dermatitis, or eczema.

Leads 102

Leads Biopharma Pharma 102

PharmExec

JUNE 25, 2023

First guidance in this area from the Agency addresses the unique challenges when designing clinical studies for these drugs

FDA 52

FDA 52

MedCity News

JUNE 25, 2023

Zocdoc recently struck a partnership with Elation Health to increase patients’ access to care. Now, any provider who uses Elation’s primary care-specific EHR can integrate their calendar into Zocdoc’s platform — meaning that the millions of patients who search for care via Zocdoc each month will have access to these providers’ real-time appointment availability.

Patients 86

Patients 86

Axtria

JUNE 25, 2023

Analyze business requirements, functionality and define project needs for Axtria’s pharma and life science clients. Translate user needs to technical documentation and provide strategic software systems solutions. Design and develop software applications with the aim of optimizing operational efficiency. Oversee ongoing support to ensure application is functioning as per specification.

Management 40

Management Pharma 40

Advertisement

Distribution

MedCity News

JUNE 25, 2023

Aledade’s $260 million financing round was led by Lightspeed Venture Partners, a new investor of the company. It also included participation from Venrock, Avidity Partners, OMERS Growth Equity and Fidelity Management and Research Company.

Networking 85

Networking Management 85

PharmExec

JUNE 25, 2023

Delivering on the mission of personalized patient support

Patients 52

Patients 52